Covered recipient · General Payments record
YULIYA YARTSEVA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,135.67
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $829.41 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $608.32 | 33 |
| Galderma Laboratories, L.P. | $163.76 | 2 |
| REVANCE THERAPEUTICS, INC. | $57.33 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $49.24 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447309 | CMS |
| ABBVIE INC. | $68.93 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447311 | CMS |
| ABBVIE INC. | $24.61 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447313 | CMS |
| ABBVIE INC. | $12.31 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447315 | CMS |
| ABBVIE INC. | $104.40 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447317 | CMS |
| ABBVIE INC. | $16.82 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447319 | CMS |
| ABBVIE INC. | $9.05 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447321 | CMS |
| ABBVIE INC. | $12.37 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447323 | CMS |
| ABBVIE INC. | $11.46 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447325 | CMS |
| ABBVIE INC. | $3.30 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447327 | CMS |
| ABBVIE INC. | $30.77 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447329 | CMS |
| ABBVIE INC. | $2.72 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447331 | CMS |
| ABBVIE INC. | $13.85 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447333 | CMS |
| ABBVIE INC. | $12.04 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447335 | CMS |
| ABBVIE INC. | $20.27 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447337 | CMS |
| ABBVIE INC. | $12.72 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447339 | CMS |
| ABBVIE INC. | $14.41 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447341 | CMS |
| ABBVIE INC. | $5.18 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447343 | CMS |
| ABBVIE INC. | $12.09 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447345 | CMS |
| ABBVIE INC. | $4.47 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447347 | CMS |
| ABBVIE INC. | $16.47 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447349 | CMS |
| ABBVIE INC. | $3.47 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447351 | CMS |
| ABBVIE INC. | $1.73 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447353 | CMS |
| ABBVIE INC. | $21.44 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447355 | CMS |
| ABBVIE INC. | $18.60 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447357 | CMS |
| ABBVIE INC. | $1.56 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447359 | CMS |
| ABBVIE INC. | $13.62 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447361 | CMS |
| ABBVIE INC. | $6.54 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447363 | CMS |
| ABBVIE INC. | $28.18 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447365 | CMS |
| ABBVIE INC. | $7.57 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447367 | CMS |
| ABBVIE INC. | $17.75 | 11/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447369 | CMS |
| ABBVIE INC. | $22.84 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447371 | CMS |
| ABBVIE INC. | $7.54 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108447373 | CMS |
| Galderma Laboratories, L.P. | $145.86 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145402023 | CMS |
| Galderma Laboratories, L.P. | $17.90 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145402025 | CMS |
| REVANCE THERAPEUTICS, INC. | $31.72 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147954268 | CMS |
| REVANCE THERAPEUTICS, INC. | $25.61 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147954270 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.